Business Wire

Backlight Announces New Organizational Structure with Two Divisions: Backlight Creative and Backlight Streaming

7.2.2023 15:00:00 CET | Business Wire | Press Release

Share

Backlight, a global media technology company that dramatically improves every stage of the video and entertainment content lifecycle, today announced a new organizational structure featuring two new divisions: Backlight Creative and Backlight Streaming. Backlight Creative includes the customers, products and teams from ftrack, iconik and Celtx, while Backlight Streaming includes the same from Zype and Wildmoka.

Since acquiring multiple fast-growing media technology brands starting in 2021, Backlight has operated as a holding company with each acquisition largely being run as independent business units. Backlight’s new divisional structure aligns complementary teams and products around shared target markets, media workflows and customers, with the goal of driving innovation, customer success and continued growth.

“This new divisional org structure will enable Backlight to better serve our rapidly growing customer base with larger, aligned teams and differentiated, integrated solutions,” said Ben Kaplan, president and CEO of Backlight. “The complementary nature and strategic synergies of our different acquisitions were central to Backlight’s original strategy and have been proven out over the past 18 months. The entire Backlight team is excited about the value that this new organizational structure will drive for our customers.”

Backlight Creative provides award-winning creative collaboration software including secure and efficient media management, production tracking, and integrated review and approval tools. Creative and video teams in film, TV, gaming, agencies and their clients rely on Backlight Creative’s iconik, ftrack and Celtx product lines to streamline creative workflows and deliver their visions accurately, on time and on budget.

Media technology veteran Mike Green has been named the Divisional CEO of Backlight Creative after serving as Backlight’s Chief Growth Officer since September 2021. Prior to joining Backlight, Green held executive strategy, marketing and corporate development positions at Brightcove, as well as executive and management positions at Comcast, Collecta and Kaboose (now Disney). Green holds degrees from Brown University and Columbia Business School.

Backlight Streaming delivers leading cloud-native solutions for OTT streaming, video management, clip creation, hyper-distribution, and monetization from its Zype and Wildmoka product lines. Leading media publishers, content providers and broadcasters rely on Backlight Streaming’s full stack software solutions to ingest, transform, manage, distribute, and monetize live and on-demand video to connect content owners to all marketplaces globally.

Ed Laczynski and Cristian Livadiotti, both co-founders and CEOs of Zype and Wildmoka respectively, are now Divisional co-CEOs of Backlight Streaming. The two CEOs have a fundamental understanding of what the Zype and Wildmoka product lines can do together, while remaining completely modular, complementary and flexible. Both Laczynski and Livadiotti co-founded and led their companies prior to their acquisitions by Backlight in 2021.

Laczynski has more than 20 years of technology leadership experience having worked with companies like IPG/McCann-Erickson, and Datapipe (now Rackspace). Laczynski holds a degree from New York University. Livadiotti has 20 years of experience in the media and telecom domains, setting up ventures, projects and organizations both in startups and large multinationals environments. He holds degrees from École Polytechnique and Télécom Paris.

About Backlight

Backlight is a global media technology company that dramatically improves every stage of the video and entertainment content lifecycle - from creation through monetization. Backed by $200M in funding from PSG, Backlight has acquired six leading media software companies since launching in 2021. Video-forward organizations solve their mission-critical business and operational challenges by partnering with Backlight’s two divisions: Backlight Creative and Backlight Streaming. Backlight Creative provides award-winning software solutions for secure and efficient media management, production tracking and creative collaboration including iconik, ftrack and Celtx. Backlight Streaming delivers leading cloud-native solutions for OTT streaming, hyper-distribution and monetization from Zype and Wildmoka. For more information visit backlight.co.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Kiní Schoop
VP, Corporate Communications
media@backlight.co

About Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

OM Pharma to Unveil the Largest Multi-Country Real-World Evidence Study on Broncho‑Vaxom® (OM‑85) for RTI Prevention at EAACI 202614.6.2026 10:00:00 CEST | Press Release

OM Pharma will reveal preliminary results from the REACH study at the European Academy of Allergy and Clinical Immunology (EAACI) Congress. REACH is the first and largest multi-country real-world evidence (RWE) study to date evaluating the impact of Broncho-Vaxom® in patients with recurrent respiratory tract infections (RTIs).1,2 The findings offer critical new clinical evidence of the therapy's effectiveness in everyday clinical practice. In a real-world cohort of 15,794 paediatric (aged >1 year), adolescent, adult and elderly patients in China, Italy, and Belgium, Broncho-Vaxom® was associated with reductions in RTI recurrence and healthcare utilisation at 12 and 24 months after treatment initiation, compared with the 12 months prior to starting the therapy.1 “The REACH real-world evidence study shows that Broncho-Vaxom® can significantly reduce infections requiring medical visits across age groups and co-morbidities,” said Anna Thomas, Chief Scientific Officer at OM Pharma. “Recurre

Incyte Announces New Positive Data at EHA 2026 Showed INCA033989 Achieved Rapid, Robust and Sustained Clinical and Molecular Responses and Was Well Tolerated in Patients with Myelofibrosis and Essential Thrombocythemia13.6.2026 17:15:00 CEST | Press Release

Incyte (Nasdaq:INCY) today announced updated clinical data from two Phase 1 studies evaluating the safety, tolerability and efficacy of INCA033989, a first-in-class mutant calreticulin (mutCALR)-targeted monoclonal antibody, in patients with mutCALR-expressing myeloproliferative neoplasms (MPNs). INCA033989 demonstrated rapid, clinically meaningful responses and consistent molecular activity across both myelofibrosis (MF) and essential thrombocythemia (ET), with convergent evidence supporting the potential for disease modification. These findings are being presented in oral and poster presentations at the European Hematology Association (EHA) 2026 Congress in Stockholm, Sweden (Session: Myeloproliferative neoplasms – Clinical, Presentation numbers: S216, PS1983, PF884). “The data presented at EHA 2026 demonstrate clinically meaningful and consistent responses with INCA033989 across both myelofibrosis and essential thrombocythemia,” said Pablo J. Cagnoni, M.D., President of Incyte and G

Results from Incyte’s Pivotal Phase 3 frontMIND Trial of Tafasitamab (Monjuvi ® /Minjuvi ® ) Combination Presented at the 2026 European Hematology Association (EHA) Congress Plenary Showed Prolonged Progression Free Survival13.6.2026 12:00:00 CEST | Press Release

Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®), a humanized Fc-modified cytolytic CD19-targeting monoclonal antibody, and lenalidomide added to R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone; Tafa-Len-R-CHOP) versus R-CHOP, the current standard of care, as a first-line treatment for adults with previously untreated diffuse large B-cell lymphoma (DLBCL) or high-grade B-cell lymphoma (HGBL). Eligible patients had an International Prognostic Index (IPI) score of 3-5, or, for patients ≤60 years of age, an age-adjusted IPI (aaIPI) of 2-3. These data are being highlighted in a prestigious Plenary Abstracts Session at the European Hematology Association (EHA) 2026 Congress, being held June 11 - 14, 2026, in Stockholm, Sweden (Abstract # S101. Plenary Abstract Session. June 13, 6:00 - 7:30 a.m. ET [12:00-1:30 p.m. CEST]). frontMIND results were als

Charlotte Tilbury awarded CBE in the King’s Birthday Honours 202612.6.2026 23:31:00 CEST | Press Release

Charlotte Tilbury CBE, sole Founder, President, Chairman and Chief Creative Officer of Charlotte Tilbury Beauty, has been awarded a Commander of the Order of the British Empire (CBE) in the King’s Birthday Honours 2026 for services to the beauty and cosmetics industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612679101/en/ Charlotte Tilbury, founder, president, chairman and chief creative officer of Charlotte Tilbury Beauty, who has been awarded a CBE (Commander of the Order of the British Empire) in 2026 for services to the beauty industry and entrepreneurship. (Photo: Charlotte Tilbury team) This honour recognises Charlotte’s contribution to leading and building Britain’s most successful global beauty brand. She has played a defining role in revolutionising the beauty industry and driving economic growth of the UK beauty sector, which has expanded from approximately £17bn in 2013 to over £31bn today. Charlotte Til

IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors12.6.2026 18:36:00 CEST | Press Release

IQM Quantum Computers, the global leader in superconducting quantum computers, today announced the appointment of Barbara Venneman to its Board of Directors. Venneman deepens the Board's expertise in digital transformation, enterprise technology commercialization, and global business scaling as IQM expands its commercial footprint worldwide. Additionally, CEO and Co-founder Jan Goetz will replace Co-founder Juha Vartiainen as the Founder representative on the IQM Board. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612650938/en/ IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors Ms. Venneman joins the IQM Board of Directors following a distinguished career at the intersection of advanced technology, strategy, and business transformation. She most recently served as Global Head of Deloitte Digital and previously held senior global leadership roles,

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye